Delta-Fly Pharma, Inc. [4598.T]
TOKYO, Apr 17 (Pulse News Wire) – Delta-fly Pharma,inc. (4598.T) reported the massive exercise of warrant shares during the period from April 1 to April 17, 2026.
According to the disclosure, Macquarie Bank Limited exercised warrants totaling 8,200 units out of the total issuance of 27.33% units, representing 19,849% of the total issuance. As of March 31, there were 19,849 unexercised warrants outstanding, which decreased to 11,649 unexercised warrants as of the latest report.
The detailed exercise status from April 1, 2026, showed the following: | Exercise Date | Number of New Shares Issued | Transfer of Treasury Shares | Exercised Warrants | |--------------|---------------------------|----------------------------|--------------------| | April 1, 2026 | - | - | 186 | | April 3, 2026 | 30,000 | - | 174 | | April 6, 2026 | 50,000 | - | 170 | | April 8, 2026 | 50,000 | - | 176 | | April 14, 2026 | 30,000 | - | 175 | | April 15, 2026 | 30,000 | - | 177 | | April 16, 2026 | 30,000 | - | 180 | | April 17, 2026 | 600,000 | - | 181 | As of the end of March 2026, the total number of issued shares was 13,175,000, including 198 treasury shares.
🟢 Confidence: High AI-translated content.